Perform Another (Advanced) Search

1.  Study Posting (799) Trial #160042, Asthma, Boston, MA
...MA Trial Information The Effect of â2-Adrenergic Polymorphisms on the Bronchoprotective Effects of Regular Salmeterol Treatment in Asthma Do you have exercise-induced asthma? The Asthma Research Center at Brigham ...
...study is to find out how one’s genetic background influences the therapeutic response to salmeterol (Sereventâ) for treatment of exercise-induced asthma. All study medication will be provided and are ...
View Page

2.  Study Posting (799) Trial #158758, Asthma, Boston, MA
...MA Trial Information The Effect of â2-Adrenergic Polymorphisms on the Bronchoprotective Effects of Regular Salmeterol Treatment in Asthma Do you have exercise-induced asthma? The Asthma Research Center at Brigham ...
...study is to find out how one’s genetic background influences the therapeutic response to salmeterol (Sereventâ) for treatment of exercise-induced asthma. All study medication will be provided and are ...
View Page

3.  Study Posting (799) Trial #157726, Asthma, Boston, MA
...MA Trial Information The Effect of â2-Adrenergic Polymorphisms on the Bronchoprotective Effects of Regular Salmeterol Treatment in Asthma Do you have exercise-induced asthma? The Asthma Research Center at Brigham ...
...study is to find out how one’s genetic background influences the therapeutic response to salmeterol (Sereventâ) for treatment of exercise-induced asthma. All study medication will be provided and are ...
View Page

4.  Newly Approved Drug Therapies (934) Brovana (arformoterol tartrate), Sepracor,
...of Brovana twice daily, 50 mcg of Brovana once daily or placebo. Both trials included salmeterol inhalation aerosol, 42 mcg twice daily as an active comparator. In both trials Brovana administered ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (16), Asthma
...were controlled oninhaled corticosteroids. Subjects received 10, 15 and 20 mcg of GSK159797 oncedaily, or salmeterol given twice daily, for 14 days. The primary endpoint wasimprovement in forced expiry volume in one second (FEV1) over baselinecorticosteroid therapy with GSK159797 versus salmeterol. All doses of GSK159797showed comparable bronchodilator activity when compared to salmeterol. Inaddition, treatment showed a ...
View Page

6.  Newly Approved Drug Therapies (848) Spiriva HandiHaler (tiotropium bromide), Boehringer Ingelheim,
...study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002;122(1):47-55. Hvizdos KM, Goa KL . Tiotropium bromide. Drugs ; 200262(8 ...
View Page

7.  CenterWatch: Clinical Trials in Category (16) Asthma
...s Hospital New! The Effect of â2-Adrenergic Polymorphisms on the Bronchoprotective Effects of Regular Salmeterol Treatment in Asthma Boston : Brigham and Women's Hospital New! The Role of Lung Volume ...
View Page